Published KIT exon 8 AA sequences in AML patients
. | 416 . | 417 . | 418 . | 419 . | 420 . | 421 . | 422 . |
---|---|---|---|---|---|---|---|
Sources . | Leu . | Thr . | Tyr . | Asp . | Arg . | Leu . | Val . |
Patient no. | |||||||
1* | Leu | Thr | Tyr | — | Arg | Leu | Val |
2* | Leu | Thr | Tyr | — | Trp | Gly | Val |
3* | Leu | Thr | Arg | — | Trp | Leu | Val |
4* | Leu | Thr | Ala | — | Arg | Leu | Val |
5 | Leu | Ile | — | — | Arg | Leu | Val |
6 | Leu | Thr | Tyr | — | — | Phe | Val |
7 | Leu | Val | — | — | Arg | Leu | Val |
8 | Leu | Arg | Gly | — | Arg | Leu | Val |
9 | Leu | Ile | — | — | Arg | Leu | Val |
10 | Leu | Asn | — | — | Arg | Leu | Val |
11 | Leu | Thr | Tyr† | Asp | Gly | Leu | Val |
Constructs | |||||||
Δ419 | Leu | Thr | Tyr | — | Arg | Leu | Val |
Δ418_419 | Leu | Thr | — | — | Arg | Leu | Val |
T417I/Δ418_419 | Leu | Ile | — | — | Arg | Leu | Val |
. | 416 . | 417 . | 418 . | 419 . | 420 . | 421 . | 422 . |
---|---|---|---|---|---|---|---|
Sources . | Leu . | Thr . | Tyr . | Asp . | Arg . | Leu . | Val . |
Patient no. | |||||||
1* | Leu | Thr | Tyr | — | Arg | Leu | Val |
2* | Leu | Thr | Tyr | — | Trp | Gly | Val |
3* | Leu | Thr | Arg | — | Trp | Leu | Val |
4* | Leu | Thr | Ala | — | Arg | Leu | Val |
5 | Leu | Ile | — | — | Arg | Leu | Val |
6 | Leu | Thr | Tyr | — | — | Phe | Val |
7 | Leu | Val | — | — | Arg | Leu | Val |
8 | Leu | Arg | Gly | — | Arg | Leu | Val |
9 | Leu | Ile | — | — | Arg | Leu | Val |
10 | Leu | Asn | — | — | Arg | Leu | Val |
11 | Leu | Thr | Tyr† | Asp | Gly | Leu | Val |
Constructs | |||||||
Δ419 | Leu | Thr | Tyr | — | Arg | Leu | Val |
Δ418_419 | Leu | Thr | — | — | Arg | Leu | Val |
T417I/Δ418_419 | Leu | Ile | — | — | Arg | Leu | Val |
Sequences of patients no. 5 to no. 11 were published by Gari et al.4 “Sources” indicate the AA sequence of KIT wild type. The lower part of the panel shows the AA sequence of mutations generated by in vitro site-directed mutagenesis using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). The correct sequence of all constructs was confirmed by complete nucleotide sequencing. The shaded areas indicate differences of the AA sequence of patient samples with exon 8 mutations to KIT-WT.
The protein sequence of KIT in exon 8 was reconstructed in 4 patients with AML M4eo that carried exon 8 mutations (patient nos. 1-4).9
ins Phe Phe.